IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Confusion and Lightheadedness Related to Calcium Channel Blocker Toxicity

Case Report, Volume 13 Issue 1 – January to March 2020

Authors

Dr Deepak Chandra1, Dr Yogita Rochlani1, Dr Deepa Jayakrishnan2, Dr Bijay Nair3
1Department of Internal Medicine, University of Arkansas for Medical Sciences, Arkansas, USA;
2Harmony Health Clinic, Arkansas, USA;
3Oncology, Kaiser-Permanente Medical Center, Roseville, California


Abstract

Calcium channel blockers are commonly used drugs to control blood pressure and heart rate. These drugs can significantly depress cardiac inotropy and chronotropy at high doses, with adverse effects. We present the case of a woman, recently started on diltiazem for hypertension, who presented with severe hypotension and bradycardia. Electrocardiogram at admission, revealed a junctional rhythm. She was initially resuscitated with intravenous fluids and atropine boluses without any response. Septic workup, cardiac biomarkers, thyroid stimulating hormone and cortisol levels were normal. Hemodynamics gradually improved on glucagon and dopamine drip. She reverted back to normal sinus rhythm in about six hours. This case illustrates the importance of medication reconciliation in patients.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician